Abstract
Background
HIV testing uptake remains low among men in sub-Saharan Africa. HIV self-testing (HIVST) at the workplace is a novel approach to increase the availability of, and access to, testing among men. However, both access and linkage to posttest services remain a challenge.
Objective
The aim of this protocol is to describe a cluster randomized trial (CRT)—Workplace-Based HIV Self-testing Among Men (WISe-Men)—to evaluate the effect of HIVST in workplace settings on the uptake of HIV testing services (HTS) and linkage to treatment and prevention services among men employed in private security services in Uganda.
Methods
This is a two-arm CRT involving men employed in private security services in two Ugandan districts. The participants in the intervention clusters will undergo workplace-based HIVST using OraQuick test kits. Those in the control clusters will receive routine HTS at their work premises. In addition to HTS, participants in both the intervention and control arms will undergo other tests and assessments, which include blood pressure assessment, blood glucose and BMI measurement, and rapid diagnostic testing for syphilis. The primary outcome is the uptake of HIV testing. The secondary outcomes include HIV status reporting, linkage into HIV care and confirmatory testing following HIVST, initiation of antiretroviral therapy following a confirmatory HIV test, the uptake of voluntary medical male circumcision, consistent condom use, and the uptake of pre-exposure prophylaxis by the most at-risk populations.
Results
Participant enrollment commenced in February 2020, and the trial is still recruiting study participants. Follow-up for currently enrolled participants is ongoing. Data collection and analysis is expected to be completed in December 2021.
Conclusions
The WISe-Men trial will provide information regarding whether self-testing at worksites increases the uptake of HIV testing as well as the linkage to care and prevention services at male-dominated workplaces in Uganda. Additionally, the findings will help us propose strategies for improving men’s engagement in HTS and ways to improve linkage to further care following a reactive or nonreactive HIVST result.
Trial Registration
ClinicalTrials.gov NCT04164433; https://clinicaltrials.gov/ct2/show/NCT04164433
International Registered Report Identifier (IRRID)
DERR1-10.2196/25099
Reference43 articles.
1. Global AIDS Update 2020. Seizing the Moment: Tackling Entrenched Inequalities to End Epidemics20202020-06-28Geneva, SwitzerlandUNAIDShttps://www.unaids.org/en/resources/documents/2020/global-aids-report
2. Global AIDS Update 2019. Communities at the Centre20192020-06-11Geneva, SwitzerlandUNAIDShttps://www.unaids.org/en/resources/documents/2019/2019-global-AIDS-update
3. Ministry of Health, UgandaUganda Population-Based HIV Impact Assessment (UPHIA) 2016-2017: Final Report2019072020-06-11Kampala, UgandaMinistry of Healthhttps://phia.icap.columbia.edu/wp-content/uploads/2019/07/UPHIA_Final_Report_Revise_07.11.2019_Final_for-web.pdf
4. Country fact sheets: UgandaAIDSInfo20202020-08-10Geneva, SwitzerlandUNAIDShttps://aidsinfo.unaids.org/
5. Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献